Latest available resultsQuarter ended June 30, 202610-Q · August 5, 2026
Filed with the SECINSULET CORP
PODDHealthcare
Next reportNovember 4, 2026Analyst forecast 1.621 $/share
Revenue
$801.70M
▲ +23.5% vs prior year% YoY
Net income
$95.00M
▲ +322.2% vs prior year% YoY
EPS
1.37$
▲ +328.1% vs prior year% YoY
Net margin
11.8%
▲ +8.4 percentage points vs prior year pp YoY
Revenue▲ +23.5 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +322.2 %
EPS▲ +328.1 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $801.70M | |
| Gross profit | $562.60M | 70.2 % |
| Operating income | $129.70M | 16.2 % |
| Net income | $95.00M | 11.8 % |
| R&D | $88.10M | 11.0 % |
| EPS (diluted) | 1.37 $ | |
| Balance sheet | ||
| Assets | $3.17B | |
| Liabilities | $1.74B | |
| Equity | $1.42B | |
| Cash | — | |
| Capital | ||
| Shares outstanding | 69.35M | as of 2026-07-29 |
| Public float | — | |